Brain Scientific Stock Performance
| BRSF Stock | USD 0.75 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Brain Scientific are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Brain Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Brain Scientific is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 68.9 K | |
| Total Cashflows From Investing Activities | -58.6 K |
Brain |
Brain Scientific Relative Risk vs. Return Landscape
If you would invest 75.00 in Brain Scientific on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Brain Scientific or generate 0.0% return on investment over 90 days. Brain Scientific is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Brain, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Brain Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brain Scientific's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Brain Scientific, and traders can use it to determine the average amount a Brain Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BRSF |
Based on monthly moving average Brain Scientific is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brain Scientific by adding Brain Scientific to a well-diversified portfolio.
Brain Scientific Fundamentals Growth
Brain Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Brain Scientific, and Brain Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Brain Pink Sheet performance.
| Return On Equity | -45.97 | |||
| Return On Asset | -1.17 | |||
| Operating Margin | (28.77) % | |||
| Current Valuation | 12.28 M | |||
| Shares Outstanding | 105.4 M | |||
| Price To Sales | 26.56 X | |||
| Revenue | 265.75 K | |||
| EBITDA | (8.32 M) | |||
| Cash And Equivalents | 3.54 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 9.97 M | |||
| Debt To Equity | 0.18 % | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (5.87 M) | |||
| Earnings Per Share | (0.29) X | |||
| Total Asset | 13.38 M | |||
About Brain Scientific Performance
By analyzing Brain Scientific's fundamental ratios, stakeholders can gain valuable insights into Brain Scientific's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Brain Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Brain Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people.Things to note about Brain Scientific performance evaluation
Checking the ongoing alerts about Brain Scientific for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Brain Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Brain Scientific generated a negative expected return over the last 90 days | |
| Brain Scientific has some characteristics of a very speculative penny stock | |
| Brain Scientific currently holds 9.97 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Brain Scientific has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Brain Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Brain Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brain Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brain to invest in growth at high rates of return. When we think about Brain Scientific's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 265.75 K. Net Loss for the year was (9.1 M) with profit before overhead, payroll, taxes, and interest of 83.23 K. | |
| Brain Scientific currently holds about 3.54 M in cash with (5.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 24.0% of Brain Scientific shares are held by company insiders |
- Analyzing Brain Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Brain Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Brain Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Brain Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Brain Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Brain Scientific's pink sheet. These opinions can provide insight into Brain Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Brain Pink Sheet analysis
When running Brain Scientific's price analysis, check to measure Brain Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brain Scientific is operating at the current time. Most of Brain Scientific's value examination focuses on studying past and present price action to predict the probability of Brain Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brain Scientific's price. Additionally, you may evaluate how the addition of Brain Scientific to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |